#

Medicine

: 43
Photo: Taljat David / Shutterstock
News·
A key Novartis drug failed to meet expectations. The stock price fell
Oura pitched itself as a technology and data platform, but many investors saw it as a trendy wellness product / Photo: Erman Gunes / Shutterstock.com
News·
A single-product company: Lessons from Oura's stalled IPO
Electra plans to use the proceeds from its IPO to fund clinical trials. Photo: FaceStock/Shutterstock
News·
Electra IPO: Shares of the developer of treatments for immune disorders and cancer are now available
Photo: Andrei Doronichevs personal archive.
Review·
Five biotech companies that Andrei Doronichev is keeping an eye on
Electricity providers are benefiting from growing demand from data centers and the industrial sector. Photo: entergy.com
Review·
Where to Invest $10,000: Betting on Chip-Free AI and Protecting Against Volatility. August Ideas
Photo: Seacalm/Shutterstock
News·
Braveheart Bio IPO: Shares in the cardiovascular drug developer are now available
Google has disbanded the team that developed the AI capable of generating 3D protein structures / Photo: Unsplash.com / Adarsh Chauhan
News·
Google has disbanded its Nobel Prize-winning team. Some of its members will join Anthropic
Pharmaceutical giant Eli Lilly is a shareholder of Scribe / Photo: sasirin pamai / Shutterstock
News·
IPO Scribe: Shares in a biotech company backed by Eli Lilly and Sanofi are now available
Galderma shares plummeted 6% on the Zurich Stock Exchange / Photo: Body Stock / Shutterstock
News·
Shares of pharmaceutical company Galderma plummeted: The U.S. has halted sales of a Botox generic
According to sources cited by the Financial Times, the pharmaceutical company AbbVie is preparing to acquire Apogee for $11 billion / Photo: abbvie.scene7.com
News·
AbbVie is preparing to acquire a dermatitis drug developer for $11 billion — FT
GMR specializes in emergency medical care / Photo: GMR
News·
GMR IPO: emergency ambulance service provider goes public
Mobia Medicals development - Vivistim device for vagus nerve stimulation / Photo: Vivistim.com
News·
Mobia Medical IPO: developer of stroke rehabilitation systems goes public
Load more